← Leaderboards
Thomas J Slaga
Amc Cancer Research Center
$5,933,051
Attributed
$7,132,607
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $712.7K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$7,132,607 · 3
By mechanism
R01$7,132,607 · 3
Top collaborators
- John Digiovanni8 shared
Others in their field
Top investigators on “Skin Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$121,104,269
- Elaine Fuchs · University Of Chicago$26,726,187
- Allan Balmain · University Of California San Francisco$25,703,743
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- Larry Arthur$22,931,757
- Janet Ellen Dancey · Queen'S University At Kingston$22,425,599
Research focus
Skin NeoplasmsKeratinocyteStagingCarcinogenesisSkin CarcinogenesisPreventReceptor FunctionPropertyInflammationCell LineEpidermisSkinGlucocorticoid ReceptorAffectSourceTumor PromotionInflammatoryTumor Suppressor ProteinsGlucocorticoidsRosemaryResearch StudyLaboratory MouseResveratrolUrsolic Acid
Grant awards (23)
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$485,169
R01 · FY2016 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$54,438
R01 · FY2016 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$436,181
R01 · FY2015 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$54,438
R01 · FY2015 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$428,277
R01 · FY2014 · CA
Anti-promoting effects of Triterpenes alone or combined with other phytochemicals$50,875
R01 · FY2014 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$422,290
R01 · FY2013 · CA
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals$467,444
R01 · FY2012 · CA
GR Impairment in Carconogenesis: Tumor Suppressor Role$299,131
R01 · FY2009 · CA · contact PI
GR Impairment in Carconogenesis: Tumor Suppressor Role$169,439
R01 · FY2009 · CA · contact PI
GR Impairment in Carconogenesis: Tumor Suppressor Role$299,131
R01 · FY2008 · CA · contact PI
Combined Natural Inhibitors in Skin Cancer Prevention$346,086
R01 · FY2007 · CA · contact PI
GR Impairment in Carconogenesis: Tumor Suppressor Role$299,131
R01 · FY2007 · CA · contact PI
Combined Natural Inhibitors in Skin Cancer Prevention$356,423
R01 · FY2006 · CA · contact PI
GR Impairment in Carconogenesis: Tumor Suppressor Role$308,065
R01 · FY2006 · CA · contact PI
Combined Natural Inhibitors in Skin Cancer Prevention$365,000
R01 · FY2005 · CA
GR Impairment in Carconogenesis: Tumor Suppressor Role$347,684
R01 · FY2005 · CA
Combined Natural Inhibitors in Skin Cancer Prevention$400,750
R01 · FY2004 · CA
Combined Natural Inhibitors in Skin Cancer Prevention$417,500
R01 · FY2003 · CA
GR IMPAIRMENT IN CARCINOGENESIS--ROLE OF NF KAPPA BETA$15,000
R01 · FY2003 · CA
GR IMPAIRMENT IN CARCINOGENESIS--ROLE OF NF KAPPA BETA$368,949
R01 · FY2002 · CA
GR IMPAIRMENT IN CARCINOGENESIS--ROLE OF NF KAPPA BETA$392,078
R01 · FY2001 · CA
GR IMPAIRMENT IN CARCINOGENESIS--ROLE OF NF KAPPA BETA$349,128
R01 · FY2000 · CA